Stock Monthly: Antibe Therapeutics drops 12% on high volatility Wednesday July 31, 2019 17:00 EDT
Jul 31, 2019 - News Bites Canadian Markets
Board and Executive Moves-Financial Results
CANADIAN MONTHLY STOCK REPORT
Antibe Therapeutics (TSXV:ATE), Canada's 22nd largest Biotechnology company by market cap, traded between an intra-month high of 33.50c and a four-month low of 28.0c. In July its volatility (highest price minus lowest price/lowest price) of 19.6% was 0.69 times average monthly volatility of 28.7%, up from 16.7% in July and 13.8% in May. The share price plummeted 4.0c (or 12.5%) in the past month to close at 28.0c on Wednesday July 31. Compared with the S&P/TSX...
Sign up today to gain access to 5 free articles a month from over 200 top subscription outlets.
Are you ready to take your business development to the next level with RelSci Professional?
Nurture your network with daily alerts that notify you when your relationships make news
Map your relationships to any target or prospect to identify a warm introduction
Access unlimited deep dossiers on over 8 million decision makers
Best of all, you can try out all these powerful business development tools absolutely free for 30 days!
Check out News Home to stay on top of the people and organizations you care most about.
